SEBI MF stress tests: Smallcap and midcap liquidation timeline disclosures

Since February 2024, the most important number for any smallcap or midcap mutual fund investor is not the fund's one-year return — it is the count of trading days it would take the scheme to sell down its portfolio in a stressed market. The Securities and Exchange Board of India (SEBI) made that figure mandatory monthly disclosure for every open-ended smallcap and midcap equity scheme, and it is published both on each asset management company's own website and on the AMFI consolidated portal. Before the market opens today, this is the structural lens worth applying to the smallcap and midcap segment, because liquidity, not valuation alone, is what decides how an exit actually behaves when everyone heads for the door at once.

The stress test framework is deliberately simple to read and hard to game. Each fund house reports the number of days required to liquidate 25% and 50% of the portfolio under a proportionate selling assumption, alongside the scheme's cash and cash equivalents, its overlap with the smallcap index, and the valuation methodology applied. The disclosure is informational; it is not a regulatory cap on how much a fund may hold or how fast it must sell. Understanding that distinction is the difference between reading the number as useful risk context and misreading it as a ceiling that does not exist.

Market Snapshot

The single data point that defines smallcap and midcap risk today is the liquidation timeline. Under the SEBI-mandated framework operative since February 2024, every smallcap and midcap scheme must state, each month, how many trading days it would need to sell 25% of its holdings and how many to sell 50%, assuming proportionate selling across the book. A longer timeline signals greater concentration in thinly traded names; a shorter one signals the manager can raise cash quickly without moving prices against the fund. The figures are refreshed monthly and the underlying methodology is reviewed quarterly under AMFI's Best Practices Guidelines.

The macro backdrop framing the equity segment is set by the Reserve Bank of India's policy stance. The repo rate stands at 5.25% following the Monetary Policy Committee's unanimous hold on 8 April 2026, the second consecutive pause after the February 2026 hold. That level followed a full year of easing through 2025, when cumulative cuts of 125 basis points brought the rate down from 6.50% to 5.25%. The MPC has retained a neutral stance, and its next scheduled review falls on 3 to 5 June 2026, which is the calendar event most likely to reset rate expectations for rate-sensitive sectors.

For investors using a systematic investment plan to build smallcap or midcap exposure, the stress test number matters more than headline performance, because it describes what happens to your money on the way out, not just on the way in. Readers can model the compounding side of that exposure with our SIP calculator and compare a one-time deployment using the lumpsum calculator.

What Moved Yesterday

The structural story in the smallcap and midcap segment over the past year has been the steady normalisation of liquidity disclosure rather than any single session's price action. When SEBI introduced the monthly stress test in February 2024, the smallcap segment had drawn regulatory attention precisely because inflows were running far ahead of the underlying liquidity of the stocks those funds were buying. The disclosure regime was the supervisory response: rather than capping flows, the regulator forced transparency on how long an orderly exit would take. Two years on, that monthly number is now a fixed part of the segment's information diet.

The mechanics of the disclosure explain why the liquidity figure moves from month to month even when a fund's holdings barely change. A scheme that grows its assets under management without a matching improvement in the tradability of its underlying stocks will see its liquidation timeline lengthen, because the same proportionate sale now represents a larger rupee value against the same daily traded volume. Conversely, a manager who raises the cash and cash equivalents component, or rotates toward more liquid names, will report a shorter timeline at the next monthly update. The number is therefore a live readout of how the manager is balancing return ambition against exit risk.

The portfolio overlap figure deserves particular attention. A high overlap with the small-cap index suggests the fund is crowded into the same names every other fund holds, which can amplify drawdowns when the whole category redeems together. A mid-cap scheme reporting a longer 50% liquidation timeline than its peers is signalling that half its book sits in stocks that cannot be sold quickly without a price impact. None of this is a verdict on the fund; it is the raw material an investor needs to judge whether the strategy's liquidity profile matches their own redemption horizon.

What to Watch Today

The first item on the calendar is the monthly stress test cycle itself. Fund houses publish updated smallcap and midcap stress test data each month on their own websites and on the AMFI portal, so investors holding these schemes should check whether their fund's 25% and 50% liquidation timelines have lengthened or shortened versus the prior month. A material lengthening, especially if AUM has grown sharply, is the kind of signal that warrants a closer look at whether the strategy still fits a near-term goal.

The second event with market-wide reach is the RBI Monetary Policy Committee review scheduled for 3 to 5 June 2026. With the repo rate held at 5.25% and the stance neutral as of 8 April 2026, the June meeting will be read closely for any shift in guidance. The RBI's own projections set the frame: CPI inflation for FY27 is projected at 4.6%, with a peak of 5.2% in the third quarter, while GDP growth for FY27 has been revised to 6.9%. Rate-sensitive segments, including financials and the broader midcap universe, tend to react to the tone of the policy statement as much as to the rate decision itself.

The third thing to watch is methodology, not market noise. AMFI reviews the stress test methodology quarterly under its Best Practices Guidelines, so a change in how liquidation timelines are computed can move the reported numbers without any change in a fund's actual holdings. Investors comparing this month's figure with an older one should confirm the methodology base is the same before drawing conclusions. For those building exposure gradually rather than in one tranche, the step-up SIP calculator helps model how rising contributions interact with a fund's AUM growth over time, which is the variable that most directly drives the liquidation timeline.

It is worth restating the limits of the disclosure. The stress test is a transparency tool, not a guarantee. It assumes proportionate selling, which may not reflect how a manager actually behaves in a crisis, and it cannot predict the depth of a future liquidity shock. SEBI's framework, detailed in its mutual fund circulars at sebi.gov.in, and the consolidated data hosted by AMFI at amfiindia.com, together give investors a standardised view that simply did not exist before February 2024. Used alongside the RBI's policy guidance at rbi.org.in, it lets a long-term investor judge liquidity risk on evidence rather than on sentiment.

FAQ

What is the SEBI mutual fund stress test?

It is a SEBI-mandated monthly disclosure, operative since February 2024, under which every open-ended smallcap and midcap equity scheme reports the number of trading days it would need to liquidate 25% and 50% of its portfolio under a proportionate selling assumption. It is published on each AMC's website and on the AMFI consolidated portal.

Where can I find my fund's stress test numbers?

Each asset management company publishes the figures on its own website, and AMFI hosts a consolidated view of all smallcap and midcap schemes at amfiindia.com. The data is updated monthly, so the most recent month's figure is the one to use.

Does a long liquidation timeline mean the fund is unsafe?

No. The stress test is informational and is not a regulatory liquidity cap. A longer timeline indicates greater concentration in less liquid stocks, which is a risk factor to weigh against your redemption horizon, but it is not a verdict on the fund's quality or strategy.

What does the 25% and 50% liquidation figure actually measure?

It measures how many trading days the scheme would need to sell 25% and 50% of its holdings respectively, assuming it sells proportionately across the portfolio. A higher cash and cash equivalents balance and lower overlap with the smallcap index generally support a shorter timeline.

How often is the stress test methodology changed?

The methodology is defined under AMFI's Best Practices Guidelines and reviewed quarterly. Because a methodology change can alter the reported numbers without any change in holdings, compare figures only across the same methodology base.

Does the RBI policy rate affect smallcap and midcap funds?

Indirectly, yes. The repo rate stands at 5.25% with a neutral stance as of 8 April 2026, and the next MPC review is 3 to 5 June 2026. Rate-sensitive sectors within the midcap universe react to policy guidance, so the June meeting is a key calendar event for these funds.

Should the stress test number drive my buy or sell decision alone?

No single metric should. The stress test should be read alongside the fund's overlap with the smallcap index, its cash buffer, its valuation methodology, and your own time horizon. It standardises liquidity information that did not exist before February 2024, but it is one input among several.